We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$27.1B
AUM Growth
+$1.07B
Cap. Flow
+$498M
Cap. Flow %
1.84%
Top 10 Hldgs %
21.61%
Holding
3,481
New
179
Increased
1,545
Reduced
1,498
Closed
172
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKTR icon
3101
Nektar Therapeutics
NKTR
$2.57B
$152K ﹤0.01%
8,192
-209
-2% -$4.41K
EGY icon
3102
Vaalco Energy
EGY
$602M
$151K ﹤0.01%
24,138
+232
+1% +$1.5K
TEI
3103
Templeton Emerging Markets Income Fund
TEI
$320M
$151K ﹤0.01%
28,393
-2,432
-8% -$13K
MGNI icon
3104
Magnite
MGNI
$3.49B
$147K ﹤0.01%
11,077
-995
-8% -$10.9K
MUFG icon
3105
Mitsubishi UFJ Financial
MUFG
$257B
$147K ﹤0.01%
13,610
+3,479
+34% +$35.3K
UA icon
3106
Under Armour Class C
UA
$2.2B
$147K ﹤0.01%
22,490
-153
-0.7% -$1.01K
AAOI icon
3107
Applied Optoelectronics
AAOI
$11.7B
$144K ﹤0.01%
17,415
-4,000
-19% -$44K
CERT icon
3108
Certara
CERT
$1.22B
$142K ﹤0.01%
10,238
-343
-3% -$5.63K
JRS icon
3109
Nuveen Real Estate Income Fund
JRS
$243M
$141K ﹤0.01%
18,391
MDXG icon
3110
MiMedx Group
MDXG
$624M
$141K ﹤0.01%
+20,414
New +$144K
PERI icon
3111
Perion Network
PERI
$377M
$141K ﹤0.01%
16,869
+1,898
+13% +$23K
MHI
3112
DELISTED
Pioneer Municipal High Income Fund
MHI
$139K ﹤0.01%
15,202
+1,584
+12% +$14K
BLNK icon
3113
Blink Charging
BLNK
$85.6M
$137K ﹤0.01%
49,900
-28
-0.1% -$80
HIX
3114
Western Asset High Income Fund II
HIX
$355M
$137K ﹤0.01%
31,521
-5,000
-14% -$22K
IGD
3115
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$524M
$136K ﹤0.01%
26,544
-2,000
-7% -$10.3K
STNE icon
3116
StoneCo
STNE
$2.43B
$134K ﹤0.01%
11,189
-43,798
-80% -$646K
ISD
3117
PGIM High Yield Bond Fund
ISD
$419M
$133K ﹤0.01%
10,347
PML
3118
PIMCO Municipal Income Fund II
PML
$497M
$132K ﹤0.01%
15,433
-1,661
-10% -$14K
OPK icon
3119
Opko Health
OPK
$1.04B
$131K ﹤0.01%
104,600
-460
-0.4% -$596
ERIC icon
3120
Ericsson
ERIC
$33.4B
$130K ﹤0.01%
21,050
-3,402
-14% -$19K
OFS icon
3121
OFS Capital
OFS
$48.6M
$129K ﹤0.01%
14,500
+2,250
+18% +$21.7K
DVAX
3122
DELISTED
Dynavax Technologies
DVAX
$127K ﹤0.01%
11,290
-1,075
-9% -$12.5K
IONQ icon
3123
IonQ
IONQ
$18.3B
$125K ﹤0.01%
17,722
-14,319
-45% -$117K
ASG
3124
Liberty All-Star Growth Fund
ASG
$349M
$123K ﹤0.01%
22,982
-1,806
-7% -$9.47K
HERZ
3125
Herzfeld Credit Income Fund
HERZ
$32.4M
$122K ﹤0.01%
5,202
+64
+1% +$1.49K

Similar funds

Cambridge Investment Research Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Cambridge Investment Research Advisors held 3,481 positions worth $27.1B, up 4.1% from $26B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambridge Investment Research Advisors's Q2 2024 filing shows 179 new, 1,545 increased, 1,498 reduced and 172 closed positions. Its largest new stake was Sila Realty Trust: 733,789 shares worth $15.5M. The largest sale was Invesco QQQ Trust, an estimated $99.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q2 2024 buy was Sila Realty Trust: 733,789 shares worth $15.5M.
  • Cambridge Investment Research Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2024, an estimated $77.4M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $99.4M.
  • Cambridge Investment Research Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.55M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2024.
  • Cambridge Investment Research Advisors opened 179 new positions and closed 172 in Q2 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $27.1B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.